Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology (2005)
  • David F. McDermott, Loyola University Chicago
  • Meredith M. Regan, Loyola University Chicago
  • Joseph I. Clark, Loyola University Chicago
  • Lawrence E. Flaherty, Loyola University Chicago
  • Geoffery R. Weiss, Loyola University Chicago
  • Theodore F. Logan, Loyola University Chicago
  • John M. Kirkwood, Loyola University Chicago
  • Michael S. Gordon, Loyola University Chicago
  • Jeffrey A. Sosman, Loyola University Chicago
  • Marc S. Ernstoff, Loyola University Chicago
  • Christopher P.G. Tretter, Loyola University Chicago
  • Walter J. Urba, Loyola University Chicago
  • John W. Smith, Loyola University Chicago
  • Kim A. Margolin, Loyola University Chicago
  • James W. Mier, Loyola University Chicago
  • Jared A. Gollob, Loyola University Chicago
  • Janice P. Dutcher, Loyola University Chicago
  • Michael B. Atkins, Loyola University Chicago
Link
Disciplines
Publication Date
January 1, 2005
DOI
10.1200/JCO.2005.03.206
Citation Information
David F. McDermott, Meredith M. Regan, Joseph I. Clark, Lawrence E. Flaherty, et al.. "Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma" Journal of Clinical Oncology Vol. 23 Iss. 1 (2005) p. 133 - 141
Available at: http://works.bepress.com/walter-urba/2/